PF-04191834 Single Dose Bronchodilatory Study In Asthma.

Completed · Phase 2 · Has a placebo group

Conditions studied: Asthma

In brief

Study to determine the bronchodilatory effects of PF-04191834 compared with zileuton in patients with asthma

Key facts

Study ID

NCT00723021

Run by

Pfizer

People needed

15

Starts

2008-07-01

Expected to finish

2009-07-01

Last updated by the study team

2013-02-01

Who can join

Age: 18 and older, up to 60. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Persistent mild/moderate asthma for at least 6 months.
• Reduced lung function
• Reversible airway obstruction

You may not qualify if…

• Pregnant/nursing females.
• Liver function tests greater than upper limit of normal (ULN)

Where it is running

• Pfizer Investigational Site — Baltimore, Maryland, United States
• Pfizer Investigational Site — North Dartmouth, Massachusetts, United States
• Pfizer Investigational Site — Kalamazoo, Michigan, United States
• Pfizer Investigational Site — Omaha, Nebraska, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.